Healthy Aging Global Leader: On Forefront Of Investigative Research
Age management leader Cenegenics® Medical Institute collaborated with medical experts on various research fronts to determine markers for aging and solutions to slow down chronic disease
Las Vegas, NV (Vocus/PRWEB) January 03, 2011
Cenegenics® Medical Institute, the global age management medicine leader, collaborated with experts on various research fronts to determine markers for aging and solutions to slow down chronic disease—investigating testosterone and growth hormone in heart failure therapy, erectile dysfunction as a complication of heart failure, the long-term safety of testosterone and growth hormone supplementation, testosterone therapy treatment of metabolic disturbances in heart failure and heart failure in the elderly.
Among the experts co-authoring with Cenegenics are Dr. Ernst R. von Schwarz, professor of medicine at UCLA’s David Geffen School of Medicine, and Dr. Enrique Ginzburg, professor of surgery at the University of Miami - Miller School of Medicine.
“Our model for proactive health is now getting good scientific support in the general medical community. So we’re very excited about the future and glad medicine is beginning to take a long, hard look at some of the protocols and approacheswe’ve been talking about since Cenegenics’ inception in 1997. Cenegenics is in the right place as a global medical practice to support adult outcome studies for the use of our program, which has always been based on a three-sided approach—nutrition/exercise, nutraceuticals and hormone optimization when clinically indicated,” Dr. Robert D. Willix, Jr. said.
Willix is co-author on the research, a former cardiovascular surgeon and chief medical officer of Cenegenics Las Vegas as well as chief medical officer and CEO of Cenegenics Boca Raton.
Papers published throughout this year—with several others positioned for 2011—are listed below:
Erectile Dysfunction as a Complication of Heart Failure. A scientific paper/expert review with Dr. Ernst R. von Schwarz giving men hope for better treatments that minimize erectile dysfunction side effects. Published by Current Health Failure Reports.
Growth Hormone and Testosterone in Heart Failure Therapy. A scientific paper/expert review with Dr. Ernst R. von Schwarz focused on the positive association between testosterone deficiency/growth hormone resistance and a poor state of heart failure. Published at Expert Opinion on Pharmacotherapy, an international, MEDLINE-indexed, peer-reviewed journal.
Vitamin D Deficiency Investigation. A scientific paper/expert review with Dr. Ernst R. von Schwarz to investigate current evidence linking vitamin D deficiency with heart failure. Published in the Journal of Cardiovascular Pharmacology and Therapeutics.
Testosterone Therapy: Treatment of Metabolic Disturbances in Heart Failure. A scientific paper/expert review with Dr. Ernst R. von Schwarz that outlines cardiovascular and peripheral effects of testosterone supplementation in patients with chronic heart failure. Published in the Journal of Cardiovascular Pharmacology and Therapeutics.
Heart Failure in Elderly: Thoughts on diastolic heart failure, medical therapy, women and end-of-life care. A scientific paper/expert review with Dr. Ernst R. von Schwarz on issues in heart failure management and requirements on understanding specific needs and challenges for healthier aging even with a chronic/incurable disease. Published in Current Opinion in Internal Medicine.
Long-Term Safety of Testosterone and Growth Hormone Supplementation: A Retrospective Study of Metabolic, Cardiovascular and Oncologic Outcomes. The second retrospective study done with Dr. Enrique Ginzburg, professor of surgery at the University of Miami - Miller School of Medicine. The much-awaited study finally gives the public good news on the safety of hormonal therapy. Published in the Journal of Clinical Medicine Research.
“We’re now seeing our hard work of getting other physicians to recognize the value of optimizing thyroid, DHEA, testosterone levels. . . not only from a metabolic point of view, but also physiologically, reducing mortality figures in cardiovascular patients and probably reducing overall mortality from all diseases when testosterone levels are kept in higher therapeutic ranger vs. the lower quartiles of hypogonadism,” Willix said.
Per Willix, Cenegenics—via its nonprofit Cenegenics Education and Research Foundation (CERF)—is staying strong on its commitment to identify institutions, researchers and research organizations who are interested in investigating markers for aging and solutions to slow down the progression of chronic disease via a proactive approach.
CERF also is forging research collaborations to investigate other avenues of the aging process—including nutraceuticals that may help slow the aging process and reduce some age-related occurrences, such as oxidative stress, telomere shortening and stem cell depletion.
For more information about Cenegenics, please visit http://www. cenegenics. com. Register for quick access to the informative Guide to Healthy Aging, Executive Summary and media excerpts. To schedule an interview, please contact Ann Castro, Cenegenics Director of Media Relations: 702.953.1588.
About Cenegenics
Cenegenics® Medical Institute—the recognized leading authority in age management medicine —offers their highly regarded approach to optimal health at centers nationwide: Las Vegas, Nevada (Cenegenics Las Vegas and Cenegenics-Life Center); Charleston, South Carolina; Boca Raton, Florida; Dallas, Texas; Fort Worth, Texas; Atlanta, Georgia; Chicago, Illinois; Beverly Hills, California; Philadelphia, Pennsylvania; Washington, DC; New York City, New York; Tulsa, Oklahoma; Jacksonville, Florida. Additional centers are scheduled to open in other metropolitan areas in the near future. With an established presence in the medical community, Cenegenics uses a proactive approach based on solid science and comprehensive evaluation. Their established protocols have been recognized as the next generation of medical science, capturing global attention. Cenegenics offers CME-accredited physician training and certification opportunities in age management medicine via the nonprofit Cenegenics Education and Research Foundation (CERF). Headquartered in Las Vegas, Cenegenics serves more than 20,000 patients worldwide—2,000 are physicians and their families.
###
